BR112014000135A2 - diagnóstico de entamoeba histolytica - Google Patents

diagnóstico de entamoeba histolytica

Info

Publication number
BR112014000135A2
BR112014000135A2 BR112014000135A BR112014000135A BR112014000135A2 BR 112014000135 A2 BR112014000135 A2 BR 112014000135A2 BR 112014000135 A BR112014000135 A BR 112014000135A BR 112014000135 A BR112014000135 A BR 112014000135A BR 112014000135 A2 BR112014000135 A2 BR 112014000135A2
Authority
BR
Brazil
Prior art keywords
diagnosis
entamoeba histolytica
histolytica
entamoeba
Prior art date
Application number
BR112014000135A
Other languages
English (en)
Inventor
Huat Lim Boon
Othman Nurulhasanah
Binti Noordin Rahmah
Kin Wong Weng
Mohamed Zeehaida
Ning Tan Zi
Original Assignee
Univ Sains Malaysia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Sains Malaysia filed Critical Univ Sains Malaysia
Publication of BR112014000135A2 publication Critical patent/BR112014000135A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
BR112014000135A 2011-07-07 2011-07-20 diagnóstico de entamoeba histolytica BR112014000135A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2011003202A MY172643A (en) 2011-07-07 2011-07-07 Diagnosis of entamoeba histolytica
PCT/MY2011/000172 WO2013006024A1 (en) 2011-07-07 2011-07-20 Diagnosis of entamoeba histolytica

Publications (1)

Publication Number Publication Date
BR112014000135A2 true BR112014000135A2 (pt) 2018-06-19

Family

ID=47437247

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014000135A BR112014000135A2 (pt) 2011-07-07 2011-07-20 diagnóstico de entamoeba histolytica

Country Status (7)

Country Link
BR (1) BR112014000135A2 (pt)
CO (1) CO6940378A2 (pt)
IN (1) IN2014CN00626A (pt)
MX (1) MX358619B (pt)
MY (1) MY172643A (pt)
WO (1) WO2013006024A1 (pt)
ZA (1) ZA201400469B (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130417A (en) * 1990-04-30 1992-07-14 Washington University Entamoeba histolytical immunogenic protein and cdna clone
MX9206019A (es) * 1992-10-20 1994-04-29 Univ Autonoma De Nuevo Leon Procedimiento para la preservacion de moleculas antigenicas sin el uso de inhibidores enzimaticos.

Also Published As

Publication number Publication date
IN2014CN00626A (pt) 2015-04-03
MY172643A (en) 2019-12-07
MX2014000007A (es) 2015-02-12
WO2013006024A1 (en) 2013-01-10
MX358619B (es) 2018-08-28
CO6940378A2 (es) 2014-05-09
ZA201400469B (en) 2015-08-26

Similar Documents

Publication Publication Date Title
CY2017025I2 (el) Αντιδοτα αντιπηκτικων
SMT201700094B (it) Composto di pirazina carbossammide
SMT201600370B (it) Complessi chelati di oligonucleotidi
CO7061086A2 (es) Combinaciones de compuestos activos
CO7010838A2 (es) Compuestos de imidazopirrolidinona
DK2934584T3 (da) Anti-gdf15-antistoffer
DK2580243T3 (da) Antibodies against human cd38
DK2850101T3 (da) Anti-FcRn-antistoffer
BR112013022325A2 (pt) montagem de cateter
BR112014005359A2 (pt) prendedor de grampo - estalar de fechar
BR112014031335A2 (pt) bloco de diagnóstico transacional
AR092198A1 (es) Derivados de pirazolopirimidinas
BR112014003878A2 (pt) síntese de r-bifenilalaninol
BR112013021219A2 (pt) filtro de área ampliada
DK2828292T3 (da) Jcv-neutraliserende antistoffer
DK3521315T3 (da) Anti-transglutaminase-2-antistoffer
DK2935330T3 (da) Anti-notch3-antistoffer
BR112014002929A2 (pt) novos anticorpos contra fosforilcolina
BR112013010270A2 (pt) polimorfos de febuxostato
FR2956419B1 (fr) Elements de construction calorifuges
ITMI20131403A1 (it) Pezzo di veicolo
DK2904166T3 (da) Afdækning
BR112014000135A2 (pt) diagnóstico de entamoeba histolytica
DK2904164T3 (da) Dæksel
ES1079132Y (es) Torsionador-armador de cuerdas mejilloneras

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL